Product Information
DOXAZOSIN MESYLATE 4 MG TAB is a generic product labeled by Accord Healthcare Inc., priced at $0.0857 per EA under NDC 16729021317. Its NADAC has been published 524 times since Aug 10, 2016.
FDA first approved this application on Jun 11, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Doxazosin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
4 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729021317
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DOXAZOSIN MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA202824FDA Approved
6/11/2014
TE Code
AB
On Market Since
4/22/2015
Pharmacological Classes
Price Statistics
The NADAC for DOXAZOSIN MESYLATE 4 MG TAB has been published 524 times since Aug 10, 2016, and over the history we have for it it has declined 81.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0857 per EA |
|---|---|
| All-time high | $0.4617 (Oct 12, 2016) |
| All-time low | $0.0813 (Jul 20, 2022) |
| 52-week high | $0.0975 |
| 52-week low | $0.0857 |
| Median price | $0.1170 |
| Average price | $0.1621 |
| Largest weekly change | -28.7% (Sep 23, 2020) |
| Weeks tracked | 524 |
| Tracking since | Aug 10, 2016 |
1W
N/A
1M
N/A
3M
-6.0%
6M
-12.2%
1Y
-6.2%
3Y
-11.4%
5Y
-31.1%
All
-81.4%
Last surveyed Aug 19, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Accord Healthcare Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Doxazosin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DOXAZOSIN MESYLATE 4 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DOXAZOSIN MESYLATE 4 MG TAB, manufactured by Accord Healthcare Inc., is $0.0857 per EA (NDC 16729021317), effective Aug 19, 2026.
How has the price of DOXAZOSIN MESYLATE 4 MG TAB changed over time?
Over the history we have for it, the NADAC for DOXAZOSIN MESYLATE 4 MG TAB has declined 81.4%. It has been tracked across 524 weekly CMS publications since Aug 10, 2016.
What are the highest and lowest recorded NADAC prices for DOXAZOSIN MESYLATE 4 MG TAB?
Since Aug 10, 2016, the NADAC for DOXAZOSIN MESYLATE 4 MG TAB has ranged from a low of $0.0813 (Jul 20, 2022) to a high of $0.4617 (Oct 12, 2016), with a median of $0.1170 per EA.
Are there cheaper alternatives to DOXAZOSIN MESYLATE 4 MG TAB?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DOXAZOSIN MESYLATE 4 MG TAB, is $0.0834 per EA — about 3% below DOXAZOSIN MESYLATE 4 MG TAB.
Who manufactures DOXAZOSIN MESYLATE 4 MG TAB?
DOXAZOSIN MESYLATE 4 MG TAB (NDC 16729021317) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.